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Most toxicologic studies focus on a single agent 
and either do not measure or do not adjust for 
potential confounding or modifying effects of 
other chemicals. Although such an approach 
has identified toxicities associated with vari-
ous chemicals, it does not reflect real-world 
scenarios in which humans are exposed to mul-
tiple chemicals (Cory-Slechta 2005; Simmons 
1995). Human exposure to chemical mixtures 
is particularly widespread in socioeconomically 
disadvantaged populations (Naess et al. 2007) 
and among populations living near hazardous 
waste sites (Hu et al. 2007). The customary 
approach of examining chemicals in isolation 
may constrain our ability to understand neuro-
logic sequelae (Bellinger 2008a; Cory-Slechta 
et al. 2008). Despite the importance of examin-
ing joint exposures to toxicants, few epidemio-
logic studies have done so. Metals, in particular, 
are common neurotoxicants occurring within 
the environments of children. Concomitant 
exposure to several metals may have more 
severe (i.e., synergistic) effects on cognition 
than expected based on effects of exposure to 
each metal alone (Wright et al. 2006).
In this article, we focus on interactions 
between lead and manganese because these 
metals share the central nervous system as their 
primary toxicity target in children. Adverse 
effects of lead on neurodevelopment are well 
described (Bellinger et al. 1991; Canfield et al. 
2003; Chen et al. 2007; Tellez-Rojo et al. 
2006). Cognitive deficits are major concerns, 
with declines of about 1.1–3.9 IQ points, for 
example, estimated for a 10-μg/dL increase in 
blood lead (Lanphear et al. 2005). Evidence 
for the neurotoxic effects of environmen-
tal manganese on children is mounting and 
includes associations with cognition, mem-
ory, behavior, and motor function (Bouchard 
et al. 2007, 2011; Claus Henn et al. 2010; 
Menezes-Filho et al. 2011; Riojas-Rodriguez 
et al. 2010; Takser et al. 2003; Wasserman 
et al. 2006; Wright et al. 2006). The mecha-
nisms for lead neurotoxicity include increased 
spontaneous release of neurotransmitters and 
disruption of calcium metabolism (Bressler 
and Goldstein 1991). Biological mechanisms 
for manganese toxicity are also hypothesized 
to involve calcium metabolism, oxidative dam-
age to neuronal cells, and impaired dopamine 
neurotransmission (Aschner and Aschner 
1991; Normandin and Hazell 2002; Verity 
1999). With the same target organ, potentially 
similar biological mechanisms, and a realistic 
potential for joint exposure, manganese and 
lead are important chemicals to examine for 
interactive effects.
Our study examined manganese–lead 
interaction in early childhood, a period of 
potentially heightened susceptibility to neuro-
toxicants. Among 1- to 3-year-old children 
in Mexico City, we prospectively examined 
whether coexposure to manganese and lead 
causes neurodevelopmental deficiencies that 
are more severe than expected based on effects 
of exposure to each metal alone.
Materials and Methods
Study population. The population of chil-
dren analyzed in this study has been described 
previously (Claus Henn et al. 2010). Briefly, 
we enrolled women just before or during 
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Ba c k g r o u n d: Most toxicologic studies focus on a single agent, although this does not reflect 
real-world scenarios in which humans are exposed to multiple chemicals.
oBjectives: We prospectively studied manganese–lead interactions in early childhood to examine 
whether manganese–lead coexposure is associated with neurodevelopmental deficiencies that are 
more severe than expected based on effects of exposure to each metal alone.
Me t h o d s : Four hundred fifty-five children were enrolled at birth in an longitudinal cohort study 
in Mexico City, provided blood samples, and were followed until 36 months of age. We measured 
lead and manganese at 12 and 24 months and assessed neurodevelopment at 6-month intervals 
from 12 to 36 months of age using Bayley Scales of Infant Development–II.
re s u l t s: Mean (± SD) blood concentrations at 12 and 24 months were, respectively, 24.7 ± 5.9 
μg/L and 21.5 ± 7.4 μg/L for manganese and 5.1 ± 2.6 μg/dL and 5.0 ± 2.9 μg/dL for lead. Mixed-
effects models, including Bayley scores at five time points, showed a significant interaction over 
time: highest manganese quintile × continuous lead; mental development score, β = –1.27 [95% 
confidence interval (CI): –2.18, –0.37]; psychomotor development score, β = –0.92 (95% CI: 
–1.76, –0.09). Slopes for the estimated 12-month lead effect on 18-month mental development and 
24- through 36-month psychomotor development scores were steeper for children with high man-
ganese than for children with midrange manganese levels.
co n c l u s i o n s: We observed evidence of synergism between lead and manganese, whereby lead tox-
icity was increased among children with high manganese coexposure. Findings highlight the impor-
tance of understanding health effects of mixed exposures, particularly during potentially sensitive 
developmental stages such as early childhood.
key w o r d s : coexposure, early childhood, lead, manganese, metals, neurodevelopment. Environ 
Health Perspect 120:126–131 (2012).  http://dx.doi.org/10.1289/ehp.1003300 [Online 
1 September 2011]Manganese and lead co-exposure and neurodevelopment
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pregnancy (n = 462) or at delivery (n = 462) 
from 1997 through 2000 in a larger study 
examining plasma lead biomarkers during 
pregnancy and neurodevelopment in Mexico 
City (Surkan et al. 2008; Tellez-Rojo et al. 
2006). For the present study, we included 
493 children who provided a blood sample 
at 12 and/or 24 months of age (12 months, 
n = 301; 24 months, n = 482) and underwent 
neuro  developmental testing. Children were 
followed through 36 months of age. The par-
ent study for this project did not include mea-
sures of blood manganese, but whole blood 
was archived during follow-up visits whenever 
possible. After exclusions [e.g., very low birth 
weight (< 1,500 g), severely premature birth 
(< 32 weeks gestation), or missing data on gesta-
tional age], 486 children (12 months, n = 296; 
24 months, n = 475) met eligibility criteria.
Eligible mothers were informed about 
the study, and written consent was obtained 
before participation. The human subjects 
committees of the National Institute of Public 
Health of Mexico, Harvard School of Public 
Health, and participating hospitals approved 
all study materials and procedures.
Measurement of blood manganese and 
lead. Venous whole blood samples were col-
lected in trace metal-free tubes from children 
at 12 and/or 24 months of age and immedi-
ately frozen. We prepared and analyzed sam-
ples for manganese and lead concentrations 
at the Trace Metals Laboratory at Harvard 
School of Public Health in Boston. We meas-
ured metals concentrations with a dynamic 
reaction cell/inductively coupled plasma 
mass spectrometer (Elan 6100; PerkinElmer, 
Norwalk, CT, USA), using previously 
described methods and quality control mea-
sures (Zota et al. 2009). Recovery rates for 
manganese and lead in quality control and 
spiked samples were 78–113%, and preci-
sion (percent relative standard deviation) was 
< 5%. The average limits of detection were 
0.09 and 0.04 μg/dL for manganese and lead, 
respectively, and all samples were above the 
limits of detection.
Measurement of child development and 
potential confounders. We assessed child neuro-
development at 6-month intervals (i.e., 12, 18, 
24, 30, 36 months of age) using the Bayley 
Scales of Infant Development–II, Spanish ver-
sion (BSID-IIS) (Bayley 1993). Trained study 
personnel, who were blinded to children’s 
manganese and lead levels, administered the 
test using a standardized protocol previously 
described by our research group (Gomaa et al. 
2002). In this study, we considered scores from 
the Mental Development Index (MDI) and 
the Psychomotor Development Index (PDI) of 
the BSID-IIS as the primary outcomes.
We collected information on demo-
graphic, socioeconomic, and other factors 
that could confound the relationship between 
manganese–lead and neurodevelopment: sex, 
hemoglobin at 12 and 24 months, ferritin at 
12 and 24 months, birth weight, birth length, 
head circumference at birth, gestational age, 
maternal age at delivery, maternal and pater-
nal education, maternal marital status at 
enrollment, duration of breast-feeding in the 
infant’s first year, and child nutrition at 12 
and 24 months collected via questionnaires. 
Umbilical cord blood lead and maternal blood 
lead at 1-month postpartum were also con-
sidered as confounders, in order to examine 
effects of metals at 12 and 24 months inde-
pendently from effects of exposures at birth. 
We assessed maternal IQ using the Wechsler 
Adult Intelligence Scale, Spanish version 
(Wechsler 1968).
Statistical analyses. Our previous analysis 
of the main effect of manganese suggested an 
inverted U-shaped association between man-
ganese and neurodevelopment at 12 months, 
whereby lower MDI scores were observed at 
the lowest and highest quintiles of the man-
ganese distribution compared with midrange 
levels of manganese (Claus Henn et al. 2010). 
We therefore examined the manganese–lead 
interaction at both the lowest and highest 
manganese quintiles (i.e., highest quintile 
manganese × lead and lowest quintile manga-
nese × lead, compared with middle manganese 
quintiles). We modeled lead as a continuous 
variable, centered at the arithmetic mean value 
of the distribution. Although manganese and 
lead data were moderately skewed, the Gauss–
Markov model requires that only the model 
residuals be normally distributed. Because 
this assumption was satisfied, we did not log 
transform the exposure variables. Skewness 
may also arise from the presence of outliers; 
the influence of identified outliers on effect 
estimates was examined in sensitivity analyses, 
as described below. Neurodevelopment scores 
were approximately normally distributed and 
were modeled as continuous outcomes.
We fit two (i.e., one for each exposure 
time point) linear mixed-effects models with 
repeated measures of Bayley scores to examine 
the manganese–lead interaction over time. 
Additionally, we fit separate adjusted regres-
sion models for each exposure time point with 
each Bayley assessment (i.e., 12-month blood 
metals with 12-, 18-, 24-, 30-, and 36-month 
Bayley scores; 24-month blood metals with 
24-, 30-, and 36-month Bayley scores). We 
adjusted all models for the same set of covari-
ates described previously (Claus Henn et al. 
2010): sex, hemoglobin (grams per deciliter; 
modeled as continuous variable), gestational 
age (weeks; continuous variable), maternal IQ 
(continuous variable), and maternal educa-
tion (years; continuous variable). We included 
known predictors of neurodevelopment or 
strong potential confounders (sex, maternal 
IQ, and education) a priori in multivariable 
regression models, based on biological plau-
sibility. To the model with a priori covariates, 
we added, one at a time, covariates that were 
associated in bivariate models (p < 0.10) with 
exposures and outcomes at any time point. 
Additional covariates were included in the 
final model if the manganese or lead effect 
estimates changed > 10%.
Although only ≤ 8% of eligible children 
(12 months, 21 of 296; 24 months, 38 of 
475) were excluded because of missing covari-
ate data, we conducted sensitivity analyses to 
evaluate the appropriateness of conducting 
a complete case analysis by comparing crude 
estimates for manganese–lead interaction 
among all eligible children (including those 
missing data) with those for participants with 
complete data. We also examined the influ-
ence of extreme observations, identified with 
the generalized extreme studentized deviate 
many-outlier procedure (Rosner 1983), by fit-
ting models with and without outliers.
We conducted statistical analyses using 
SAS (version 9.2; SAS Institute, Inc., Cary, 
NC, USA) and R (version 2.7.1; R Foundation 
for Statistical Computing, www.r-project.org). 
We considered results statistically significant 
at p < 0.05.
Results
Participant characteristics. From among 486 
children who met eligibility criteria (12-month 
blood metals, n = 296; 24-month blood met-
als, n = 475), 455 had complete covariate data 
(12 months, n = 275; 24 months, n = 437) 
and were included in all analyses. More blood 
samples were collected at 24 months than at 
12 months because these were convenience 
samples that depended on availability of a 
phlebotomist. Children with blood metals at 
12 months were largely a subset of the chil-
dren with blood metals data at 24 months and 
appeared similar on sociodemographic charac-
teristics [see Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1003300)]. 
In Table 1, we present major characteristics 
of children included in the analyses. Children 
included were similar to those who were 
excluded on most variables. Children who 
provided a blood sample at a single time point 
appeared similar on major characteristics to 
those who provided blood samples at both 
time points (data not shown).
Blood manganese and lead concentrations. 
The arithmetic mean (± SD) concentrations at 
12 and 24 months were, respectively, for blood 
manganese, 24.7 ± 5.9 μg/L (range, 15.3–73.9) 
and 21.5 ± 7.4 μg/L (range, 5.1–93.5), and for 
blood lead, 5.1 ± 2.6 μg/dL (range, 1.5–21.4) 
and 5.0 ± 2.9 μg/dL (range, 1.3–37.2). 
Concentrations were significantly positively 
correlated at 12 and 24 months for both blood 
manganese (Spearman correlation = 0.56, 
p < 0.0001) and blood lead (Spearman Claus Henn et al.
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correlation = 0.61, p < 0.0001). At 24 months, 
manganese and lead concentrations were also 
positively, but weakly, cor  related (Spearman 
correlation = 0.14, p = 0.004). Lead concen-
trations were higher among boys than among 
girls at 12 and 24 months, although the differ-
ence was significant only at 24 months (mean 
± SD: 12 months, boys, 5.3 ± 2.7 μg/dL; girls, 
4.9 ± 2.5 μg/dL; 24 months, boys, 5.3 ± 3.3 
μg/dL; girls, 4.7 ± 2.4 μg/dL). We observed 
no significant sex differences in blood manga-
nese levels. There were negligible differences in 
mean lead concentrations among manganese 
quintiles (data not shown).
Associations of coexposure with mental 
development. Twelve-month blood metals. 
Table 2 summarizes results from adjusted 
mixed-effects models of 12-month blood 
metals, which included MDI scores at all five 
time points. We observed a significant man-
ganese–lead interaction over time for children 
in the highest quintile of 12-month blood 
manganese [adjusted β = –1.27 (95% con-
fidence interval [CI]: –2.18, –0.37)]. Given 
these estimates, we expect MDI scores to 
decline by 0.07 points per 1-μg/dL increase 
in lead among children with midrange man-
ganese levels, compared with a decline of 
2.23 points (i.e., βmanganese quintile 5 + βlead 
+ βmanganese quintile 5 × lead = –0.89 + –0.07 + 
–1.27) per 1-μg/dL increase in lead among 
children with high manganese levels. Results 
from adjusted regression models of 12-month 
blood metals with MDI scores at five sepa-
rate time points are presented in Table 3. A 
significant manganese–lead interaction was 
observed only at 18 months for children in 
the highest quintile of 12-month blood man-
ganese [β = –1.74 (95% CI: –3.00, –0.49)]. 
At 18 months, MDI scores are expected to 
decline 0.01 points per 1-μg/dL increase in 
lead among children with midrange man-
ganese levels, compared with 1.80 points 
(i.e., –0.05 + –0.01 + –1.74) among children 
with high manganese levels. Although effect 
estimates at other time points of MDI were 
not statistically significant, coefficients were 
all negative and approached significance at 
24 months of age (p = 0.07). Furthermore, 
when we included a three-way interaction 
term (i.e., lead × highest quintile of manga-
nese × time) in the mixed-effects model to 
examine whether the manganese–lead interac-
tion changed over time, we observed no time 
trend [β = –0.07 (95% CI: –0.46, 0.32)].
We observed no manganese–lead interac-
tion among children in the lowest quintile of 
12-month blood manganese [Table 2; adjusted 
β = –0.31 (95% CI: –1.25, 0.62)]. Therefore, 
we collapsed quintiles 1–4 and compared the 
association between lead and MDI in the 
highest manganese quintile to that in the lower 
four manganese quintiles. Figure 1 shows a 
steeper regression line for the association of 
lead with 18-month MDI among children 
in manganese quintile 5 versus quintiles 1–4, 
providing evidence for increased lead toxicity 
in the presence of high manganese levels [lead 
× quintile 5 manganese, adjusted β = –1.70 
(95% CI: –2.95, –0.44)].
Twenty-four–month blood metals. We 
fit regression models for 24-month blood 
metals with 24-, 30-, and 36-month MDI 
separately, as well as in repeated measures 
models, but observed no significant manga-
nese–lead interaction at either low or high 
manganese (Table 2).
Associations of coexposure with psycho  motor 
development. Twelve-month blood metals. 
From repeated measures models, PDI scores 
are expected to decline by 0.27 points per 
1-μg/dL increase in lead among children with 
midrange manganese levels, compared with a 
decline of 1.24 points (i.e., βmanganese quintile 5 + 
βlead + βmanganese quintile 5 × lead = –0.05 + –0.27 
+ –0.92) per 1-μg/dL increase in lead among 
children with high manganese levels (Table 2). 
This suggests more severe adverse effects of 
lead on psychomotor development among 
children with high manganese. Lower PDI 
scores were also observed in separate models 
at 18, 24, 30, and 36 months among children 
with a 1-μg/dL increase in 12-month lead and 
high manganese coexposure, compared with 
children with a 1-μg/dL increase in lead but 
only midrange manganese levels (Table 3). 
Effect estimates were consistent from 18 
to 36 months and were statistically signifi-
cant at 24, 30, and 36 months [24 months, 
adjusted β = –1.60 (95% CI: –2.93, –0.27); 
Table 1. Sociodemographic characteristics of study participants and nonparticipants (mean ± SD or %).
Characteristic Children included in analysesa Nonparticipantsb
Sex (% male) 50.6 44.2
Birth weight (kg) 3.1 ± 0.4 3.1 ± 0.5
Estimated gestational age (weeks) 38.9 ± 1.3 38.4 ± 2.1
Birth length (cm) 49.8 ± 2.2 49.5 ± 3.1
Head circumference at delivery (cm) 34.1 ± 1.6 34.0 ± 1.6
Blood manganese (μg/L)
12 monthsc 24.7 ± 5.9 —
24 monthsd 21.5 ± 7.4 —
Blood lead (μg/dL)
Umbilical corde 4.7 ± 3.1 4.8 ± 2.6
12 monthsc 5.1 ± 2.6 —
24 monthsd 5.0 ± 2.9 —
Hemoglobin (g/dL)
12 months 11.8 ± 1.3 11.8 ± 1.3
24 months 12.6 ± 1.1 12.1 ± 1.4
Bayley MDI Score (36 months)f 93.2 ± 9.1 93.1 ± 8.9
Bayley PDI Score (36 months)f 95.8 ± 10.9 95.6 ± 11.5
Maternal marital status (% married) 72.6 75.9
Maternal IQ 88.0 ± 13.0 89.0 ± 11.7
Maternal education (years) 10.7 ± 2.8 11.2 ± 3.6
Maternal age at delivery (years) 25.8 ± 5.3 27.8 ± 5.4
Maternal whole-blood lead (μg/dL)g 7.5 ± 4.6 7.3 ± 4.2
an = 455 except where noted. bNonparticipants (n = 165) are children who did not provide a blood sample (n = 127) or 
Bayley score (n = 2), had incomplete covariate data (n = 33) or inadequate blood data (n = 1), or were low gestational 
age (< 32 weeks, n = 2). cn = 275. dn = 437. en = 290. fOnly 36-month Bayley scores are provided, for brevity; scores at 
other time points are similar. gCollected at 1-month postpartum.
Table 2. Effect estimates from mixed modelsa of 12- and 24-month metal concentrations with repeated 
measures of Bayleyb scores [β-coefficient (95% CI)].
Exposure Twelve monthsc  Twenty-four monthsd
MDI
Manganese (quintile 1e vs. quintiles 2–4) –2.08 (–3.98, –0.19) –0.34 (–2.35, 1.67)
Manganese (quintile 5f vs. quintiles 2–4) –0.89 (–2.79, 1.00) 0.01 (–1.97, 2.00)
Lead (μg/dL)g –0.07 (–0.39, 0.25) –0.08 (–0.46, 0.30)
Manganese (quintile 1) × lead –0.31 (–1.25, 0.62) –0.02 (–0.98, 0.94)
Manganese (quintile 5) × lead –1.27 (–2.18, –0.37) –0.09 (–0.63, 0.45)
PDI
Manganese (quintile 1 vs. quintiles 2–4) 0.47 (–1.28, 2.22) –0.22 (–2.08, 1.65)
Manganese (quintile 5 vs. quintiles 2–4) –0.05 (–1.80, 1.70) 0.06 (–1.77, 1.90)
Lead (μg/dL) –0.27 (–0.56, 0.02) –0.18 (–0.53, 0.17)
Manganese (quintile 1) × lead 0.10 (–0.76, 0.97) 0.23 (–0.66, 1.13)
Manganese (quintile 5) × lead –0.92 (–1.76, –0.09) 0.18 (–0.32, 0.68)
aAdjusted for sex, gestational age, hemoglobin, maternal IQ, maternal education, and visit. bEffect estimates for 12-month 
metals are from repeated measures models that included Bayley scores at 12, 18, 24, 30, and 36 months. Effect estimates 
for 24-month metals are from repeated measures models that included Bayley scores at 24, 30, and 36 months. cn = 275. 
For MDI, number of observations = 1,330; for PDI, number of observations = 1,329. dn = 437. For MDI and PDI, number of 
observations = 1,240. eRange: 12 months, 15.30–20.16 μg/L; 24 months, 5.06–15.57 μg/L. fRange: 12 months, 28.14–73.95 μg/L; 
24 months, 25.78–93.53 μg/L. gBlood lead centered at mean: 12 months, 5.09 μg/dL; 24 months, 4.98 μg/dL.Manganese and lead co-exposure and neurodevelopment
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30 months, adjusted β = –1.69 (95% CI: 
–3.21, –0.17); 36 months, adjusted β = –1.92 
(95% CI: –3.56, –0.28)]. Although individual 
interaction effect estimates appeared to become 
stronger over time, the three-way interaction 
term lead × highest quintile of manganese × 
time) in the mixed-effects model did not reach 
statistical significance [β = –0.31 (95% CI: 
–0.64, 0.02)].
At low blood manganese levels, we did not 
observe a manganese–lead interaction. Figure 2 
shows increased sensitivity to adverse lead 
effects on 24-month PDI among children with 
blood manganese in quintile 5 versus quin-
tiles 1–4 [lead × highest manganese quintile, 
adjusted β = –1.57 (95% CI: –2.89, –0.25)].
Twenty-four–month blood metals. As 
with mental development, we observed no 
significant interactions between 24-month 
manganese and lead on psychomotor devel-
opment (Table 2).
Sensitivity analyses. Crude estimates for 
12-month manganese–lead interaction among 
all children, including those missing covariate 
data, were weaker than those for study partici-
pants with complete data but still suggest lower 
neurodevelopment scores with coexposure [e.g., 
crude β for interaction between manganese 
quintile 5 × continuous lead, 18-month MDI: 
all children, –0.96 (95% CI: –1.86, –0.06); 
children with complete data, –1.72 (95% CI: 
–2.95, –0.49); 30-month PDI; all children, 
–0.54 (95% CI: –1.64, 0.56); children with 
complete data, –1.74 (95% CI: –3.23, –0.25)]. 
In the subset of children who provided blood 
samples at both 12 and 24 months (n = 267 
vs. total n = 275 for 12-month samples), results 
from 12-month metal analyses were similar 
[e.g., mixed-effects model adjusted β, manga-
nese quintile 5 × continuous lead predicting 
MDI: subset of 267 children, –1.26 (95% CI: 
–2.17, –0.37); total sample, –1.27 (95% CI: 
–2.18, –0.37)]. For 24-month metal analyses, 
results for MDI among the subset of 267 chil-
dren with both 12- and 24-month blood sam-
ples were generally consistent with results based 
on all 24-month samples [n = 437; mixed-
  effects model adjusted β, manganese quintile 
5 × continuous lead: subset of 267 children, 
–0.53 (95% CI: –1.41, 0.35); total sample, 
–0.09 (95% CI: –0.63, 0.45)]. For PDI, 
however, we observed a negative interaction 
between 24-month lead and manganese only 
among the subset of children with both 12- 
and 24-month blood samples [mixed-  effects 
model adjusted β, manganese quintile 5 
× continuous lead: subset, –0.86 (95% CI: 
–1.66, –0.05); total sample, 0.18 (95% CI: 
–0.32, 0.68)]. When we excluded six outliers 
of 12-month blood levels (three highest man-
ganese and lead levels) from analyses, effect 
estimates for the interaction between lead and 
high manganese on neurodevelopment were 
similar [e.g., mixed-effects model adjusted 
β, MDI: excluding outliers, –1.39 (95% CI: 
–2.36, –0.41); total sample, –1.27 (95% CI: 
–2.18, –0.37); PDI: excluding outliers, –1.00 
(95% CI: –1.90, –0.10) ; total sample, –0.92 
(95% CI: –1.76, –0.09)]. We also conducted 
analyses excluding one participant who had 
very low MDI and PDI scores at 24 months 
(scores of 50 for both), and results were similar, 
with the exception of a weaker effect estimate 
for 24-month PDI [adjusted β, manganese 
quintile 5 × continuous lead: excluding par-
ticipant, –1.01 (95% CI: –2.32, 0.30); total 
sample, –1.60 (95% CI: –2.93, –0.27)]. 
Discussion
This study suggests that joint exposure to 
manganese and lead is associated with greater 
deficits in both mental and psychomotor 
Figure 1. Scatterplots and regression lines of 12-month blood lead (BPb) and 18-month MDI among chil-
dren with 12-month blood manganese (Mn) in quintiles 1–4 (A) and quintile 5 (B).
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Figure 2. Scatterplots and regression lines of 12-month blood lead (BPb) on 24-month PDI among children 
with 12-month blood manganese (Mn) in quintiles 1–4 (A) and quintile 5 (B).
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Table 3. Interaction coefficients from regression modelsa of 12-month metals and five time points of 
Bayley scores [β-coefficient (95% CI)].
Outcome  n Manganese (quintile 1)b × leadc,d Manganese (quintile 5)e × leadc,d
MDI
12 months 275 –0.11 (–1.42, 1.20) –0.94 (–2.21, 0.33)
18 months 272 –0.87 (–2.16, 0.42) –1.74 (–3.00, –0.49)
24 months 273 0.63 (–1.18, 2.44) –1.62 (–3.36, 0.12)
30 months 260 –0.03 (–1.41, 1.35) –1.08 (–2.42, 0.26)
36 months 250 0.46 (–0.93, 1.84) –1.10 (–2.44, 0.24)
PDI
12 months 275 0.69 (–0.50, 1.89) 0.15 (–1.00, 1.31)
18 months 271 –0.69 (–2.08, 0.71) –1.20 (–2.45, 0.05)
24 months 273 –0.21 (–1.59, 1.18) –1.60 (–2.93, –0.27)
30 months 260 0.51 (–1.06, 2.07) –1.69 (–3.21, –0.17)
36 months 250 –1.12 (–2.82, 0.58) –1.92 (–3.56, –0.28)
aAdjusted for sex, gestational age, hemoglobin, maternal IQ, and maternal education. Manganese and lead included as 
main effects. bRange, 15.30–20.16 μg/L. cBlood lead variable centered at mean: 5.09 μg/dL. dCompared with manganese 
quintiles 2–4. eRange, 28.14–73.95 μg/L. Claus Henn et al.
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development than expected based on effects of 
exposure to either metal alone. Interestingly, 
this interaction was observed for 12-month 
but not for 24-month blood metal concentra-
tions. A possible interpretation of the speci-
ficity of the interaction of 12-month blood 
manganese–lead levels is that this is a sensitive 
developmental window specific to this inter-
action. From repeated measures models, for a 
one-unit increase in lead at 12 months, MDI 
scores were 2.16 points lower among chil-
dren with high manganese (–0.89 + –0.07 + 
–1.27 = –2.23), compared with children with 
midrange manganese [–0.07 (95% CI: –0.39, 
0.25)]. PDI scores for a one-unit increase in 
lead at 12 months were 0.97 points lower 
among children with high manganese (–0.05 
+ –0.27 + –0.92 = –1.24), compared with 
children with midrange manganese [–0.27 
(95% CI: –0.56, 0.02)]. Although these dif-
ferences represent a small decrease in MDI 
and PDI scores for an individual, they may 
have large implications for the population 
level, because the entire distribution of neuro-
development scores may shift, increasing the 
number of children with neurodevelopmental 
deficits that are of clinical concern.
The association between lead and Bayley 
scores was similar among children with low 
versus midrange manganese levels (i.e., no 
evidence of interaction). Although children in 
the lowest quintile of blood manganese had 
lower 12- and 18-month MDI scores than 
did children in quintiles 2–4, this association 
was observed only in the absence of a change 
in blood lead [manganese quintile 1, adjusted 
β = –2.86 (95% CI: –5.52, –0.21) and –3.36 
(95% CI: –5.98, –0.74) at 12 and 18 months, 
respectively]. An independent effect of low 
manganese is consistent with its function as 
an essential nutrient, because manganese is 
a key component of various metalloenzymes 
needed for normal central nervous system 
function and protection against oxidative 
injury (Aschner and Aschner 1991). The lack 
of an interaction with lead at low manga-
nese levels may be because the mechanisms 
by which manganese deficiency causes adverse 
effects may not overlap with those for lead, 
unlike manganese toxicity. Alternatively, the 
lowest levels observed in our population may 
not be low enough to produce an effect.
In another epidemiologic study that exam-
ined manganese–lead coexposure, Kim et al. 
(2009) reported significant inverse associations 
of lead with full-scale and verbal IQ among 
school-age children with manganese concen-
trations > 14 μg/L but not among children 
with levels < 14 μg/L. Although manganese 
and lead concentrations were lower than in 
our study [mean levels of 1.7 μg/dL lead and 
14.3 μg/L manganese in Kim et al. (2009) vs. 
5.0 μg/dL lead and 21.5 μg/L manganese for 
24-month blood metals in the present study], 
the results are consistent across the two stud-
ies. An interaction between manganese and 
lead has also been seen in laboratory studies. 
In adult rats, exposure to manganese and lead 
resulted in synergistic effects on in vivo dop-
amine release (Rodriguez et al. 1998). In other 
laboratory studies, manganese exposure poten-
tiated lead effects on learning and behavioral 
patterns and increased accumulation of met-
als in rat brains (Chandra et al. 1981, 1983; 
Shukla and Chandra 1987). Kalia et al. (1984) 
proposed that the presence of excess manga-
nese in the brain may increase the binding 
affinity of brain proteins to lead or may induce 
expression of a lead-binding protein, resulting 
in more toxicity than expected based on effects 
of exposure to lead alone.
A direct comparison of manganese levels 
in our study with other studies is not possible 
because, to our knowledge, our study is the 
first to measure blood manganese in 12- and 
24-month-olds. The average blood manganese 
levels among our participants are lower than 
average cord blood manganese reported previ-
ously by Takser et al. (2003) (38.5 μg/L) and 
by Zota et al. (2009) (40 μg/L) and higher 
than levels reported in 10-year-old children 
(12.8 μg/L) (Wasserman et al. 2006). This is 
consistent with evidence of declining manga-
nese with increasing age (Chan et al. 1992; 
Collipp et al. 1983; Spencer 1999).
Our previous work, which reported lower 
MDI scores among children with both low 
and high manganese after adjusting for lead, 
found the strongest manganese associations at 
12 months (Claus Henn et al. 2010). This asso-
ciation was not seen at later ages, suggesting a 
diminution over time. When lead and man-
ganese exposures occur jointly at 12 months; 
however, the detrimental impact may be more 
enduring, because we see decrements in Bayley 
scores of similar magnitude at all ages stud-
ied. When results from both of our studies 
are taken together, it appears that, although 
blood manganese is associated with deficits 
in concurrent 12-month neuro  development 
test scores, a subset of children with lead coex-
posure have adverse manganese effects that 
persist. Because environmental manganese and 
lead frequently occur together in urban and/or 
contaminated areas (Aelion et al. 2009; Joselow 
et al. 1978), these results, if confirmed in other 
studies, may have implications for including 
the joint impact of chemicals in risk assess-
ment and public health interventions rather 
than focusing on the independent effects of 
individual toxicants.
Limitations. We did not conduct a formal 
exposure assessment of these children and are 
thus unable to identify sources of metals expo-
sure. However, blood lead levels among chil-
dren residing in Mexico City during the time 
of this study (1997–2000) have been asso-
ciated most strongly with the use of leaded 
gasoline and lead-glazed ceramics (Romieu 
et al. 1995). Elevated blood manganese levels 
likely arise from exposure to manganese in 
air, drinking water, or dietary sources, but 
differences in manganese levels among chil-
dren with the same environmental exposures 
may also arise from variability in metabolic 
function that alters retention/excretion of 
internal manganese. Although it is unclear 
which biological matrix best represents man-
ganese exposure, blood manganese is believed 
to be a reasonable indicator of environmental 
exposure and body burden (Agency for Toxic 
Substances and Disease Registry 2008).
Bayley scores may seem low relative to the 
expected mean score of 100 in a standard U.S. 
population. However, the BSID-IIS used in 
this study are not normalized to the Mexican 
population. Scores should therefore not be 
interpreted as low or be compared with other 
populations. Test results are internally valid 
and may be used to compare scores within this 
population but are not generalizable to other 
populations, which is a limitation of the study.
We lack data on socioeconomic status 
(SES) and quality of the home environment, 
two potential confounders of the relation-
ship between manganese–lead and neuro-
development. In the context of the present 
study, if social environment is associated 
with lead–manganese exposure and devel-
opment, it may confound the “interaction” 
of these two metals. However, adjusting for 
maternal education, which is strongly cor-
related with SES among families in Mexico 
(Bronfman et al. 1988), likely addresses, at 
least in part, potential confounding by this 
variable. Furthermore, both SES and home 
environment are social influences that may 
also represent exposure opportunity. If these 
exposures and these variables are intertwined, 
adjusting for SES or home environment 
may mask the complete effects of exposure 
and may be inappropriate (Bellinger 2008b, 
2009). Nonetheless, unmeasured and residual 
confounding remains possible. We also lack 
data on prenatal blood metals concentrations, 
which prevented us from assessing whether 
exposure before birth is more predictive of 
neurodevelopment in early childhood.
There may be concerns about selection 
bias due to the imbalance in the numbers of 
children for whom blood samples were avail-
able. Although some children provided only 
one sample whereas others provided two, we 
found no difference in major characteristics of 
these two groups (data not shown). However, 
we did observe a difference between 24-month 
metals interaction effect estimates for PDI 
based on all children with a 24-month sam-
ple and those based on children with both 
a 12- and 24-month sample. Although no 
differences in effect estimates were observed 
for MDI or for 12-month metals, we cannot Manganese and lead co-exposure and neurodevelopment
Environmental Health Perspectives  •  v o l u m e  120 | n u m b e r 1 | January 2012  131
exclude the possibility of a systematic dif-
ference between children who provided one 
blood sample versus two. This may also be a 
chance finding. Bias due to differential loss 
to follow-up is unlikely to alter conclusions 
because the attrition rate was low (9%) over 
the 2-year follow-up period. Effect estimates 
appear fairly robust, because interaction coeffi-
cients remained stable after excluding outliers, 
and crude estimates changed only minimally 
after controlling for sex, hemoglobin, gesta-
tional age, maternal IQ, and maternal educa-
tion [for crude estimates, see Supplemental 
Material, Table 2 (http://dx.doi.org/10.1289/
ehp.1003300)].
Strengths. This is the first prospective epi-
demiologic study to examine manganese–lead 
coexposure and neurodevelopment. With 
blood metal measurements at two time points 
in early childhood, a period of rapid brain 
development and potentially increased sensi-
tivity, we were able to begin to assess effects of 
coexposures during critical windows of devel-
opment. In addition, our repeated measure-
ments of neurodevelopment between 12 and 
36 months allowed us to evaluate persistence 
of associations and to fit repeated measures 
models with greater statistical power than is 
possible with cross-sectional analyses. Finally, 
our study population was stable, with little 
attrition and relative homogeneity in demo-
graphics that could act as confounders.
Conclusion
We observed evidence of increased lead toxic-
ity among young children with high manga-
nese coexposure. Our study findings highlight 
the importance of understanding health effects 
of mixed exposures, particularly during poten-
tially sensitive life stages of development such 
as early childhood. Future research should 
emphasize coexposures to these neurotoxicants 
in other populations examined prospectively.
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